Skip to main content
. 2017 Mar 7;19:44. doi: 10.1186/s13075-017-1241-0

Fig. 2.

Fig. 2

Distribution of FCGR and BAFF promoter gene polymorphisms in the patients who developed late-onset neutropenia (LON) during follow-up and the matched control patients who did not (non-LON). BAFF B-cell-activating factor